---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-006028"
form_type: "8-K"
ticker: "MGX"
cik: "0001785279"
company_name: "Metagenomi Therapeutics, Inc."
filed_at: "2025-01-16T23:59:59+00:00"
generated_at: "2026-05-28T00:11:18.046600+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "medium"
source: SEC EDGAR
---

# Metagenomi adds Eric Bjerkholt to board; board size increases to six

## Summary
- Eric Bjerkholt appointed as Class II director effective Jan 27, 2025; board expands from five to six.
- Bjerkholt is CFO of Mirum Pharmaceuticals; previously CFO at Chinook, Aimmune, Sunesis.
- He will serve on Audit and Compensation Committees; receives initial option grant of 42,000 shares vesting over 3 years.
- Company updated investor deck for J.P. Morgan Healthcare Conference; no specific pipeline details disclosed.

## SEC filing metadata
- accession: 0000950170-25-006028
- form_type: 8-K
- ticker: MGX
- cik: 0001785279
- company_name: Metagenomi Therapeutics, Inc.
- filed_at: 2025-01-16T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: medium
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1785279/000095017025006028/0000950170-25-006028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1785279/000095017025006028/mgx-20250113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-006028
- JSON: https://secwatch.observer/filing/0000950170-25-006028.json
- Plain text: https://secwatch.observer/filing/0000950170-25-006028.txt

## Key facts
- Executive change
  Eric Bjerkholt was appointed as Class II Director at Metagenomi Therapeutics, Inc..
  - Action: appointed
  - Role: Class II Director
  source text: appointed Eric Bjerkholt to serve as a director of the Board, each effective as of January 27, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/1785279/000095017025006028/0000950170-25-006028-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.